Gender-specific and menstrual cycle dependent differences in circulating microparticles

Platelets

Volumn 18, Issue 7, 2007, Pages 515-521

  Toth, Bettina ^a   Nikolajek, Katharina ^a   Rank, Andreas ^b   Nieuwland, Rienk ^c   Lohse, Peter ^b   Pihusch, Verena ^b   Friese, Klaus ^a   Thaler, Christian J ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Circulating microparticles; Gender; Menstrual cycle; Venous thromboembolism

Indexed keywords

CD61 ANTIGEN; CD63 ANTIGEN; D DIMER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HEMOSTATIC AGENT; LIPOCORTIN 5; MICROPARTICLE; PADGEM PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL SUBPOPULATION; CONTROLLED STUDY; DATA ANALYSIS; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; LUTEAL PHASE; MALE; MENSTRUAL CYCLE; PRIORITY JOURNAL; SEX DIFFERENCE; STATISTICAL ANALYSIS;

ADULT; ANNEXIN A5; BLOOD COAGULATION; BLOOD PLATELETS; CASE-CONTROL STUDIES; E-SELECTIN; ENDOTHELIAL CELLS; FEMALE; HUMANS; LUTEAL PHASE; MALE; P-SELECTIN; PARTICLE SIZE; SEX FACTORS;

EID: 35648994415     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100701525843     Document Type: Article

References (52)

1. Berckmans RJ, Neiuwland R, Boing AN, Romijn FP, Hack CE, Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001;85:639-646.
2. Bernal-Mizrachi L, Jy W, Jimenez JJ, Pastor J, Mauro LM, Horstman LL, de Marchena E, Ahn YS. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J 2003;145:962-970.
3. Berckmans RJ, Nieuwland R, Tak PP, Boing AN, Romijn FP, Kraan MC, Breedveld FC, Hack CE, Sturk A. Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism. Arthritis Rheum 2002;46:2857-2866.
4. Biro E, Sturk-Maquelin KN, Vogel GM, Meuleman DG, Smit MJ, Hack CE, Sturk A, Nieuwland R. Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J Thromb Haemost 2003;1:2561-2568.
5. Tushuizen ME, Nieuwland R, Rustemeijer C, Hensgens BE, Sturk A, Heine RJ, Diamant M. Elevated endothelial microparticles following consecutive meals are associated with vascular endothelial dysfunction in Type 2 Diabetes. In: Diabetes Care; 2007;30:728-730.
6. Preston RA, Jy W, Jimenez JJ, Mauro LM, Horstman LL, Valle M, Aime G, Ahn YS. Effects of severe hypertension on endothelial and platelet microparticles. In: Hypertension; 2003;41:211-217.
7. Morel O, Jesel L, Freyssinet JM, Toti F. Elevated levels of procoagulant microparticles in a patient with myocardial infarction, antiphospholipid antibodies and multifocal cardiac thrombosis. In: Thromb J; 2005;11:15.
8. Nieuwland R, Berckmans RJ, McGregor S, Boing AN, Romijn FP, Westendorp RG, Hack CE, Sturk A. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 2000;95:930-935.
9. Dignat-George F, Camoin-Jau L, Sabatier F, Arnoux D, Anfosso F, Bardin N, Veit V, Combes V, Gentile S, Moal V, Sanmarco M, Sampol J. Endothelial microparticles: A potential contribution to the thrombotic complications of the antiphospholipid syndrome. In: Thromb Haemost; 2004;91:667-673.
10. Minagar A, Jy W, Jimenez JJ, Sheremata WA, Mauro LM, Mao WW, Horstman LL, Ahn YS. Elevated plasma endothelial microparticles in multiple sclerosis. Neurology 2001;56:1319-1324.
11. Gonzalez-Quintero VH, Jimenez JJ, Jy W, Mauro LM, Hortman L, O'Sullivan MJ, Ahn Y. Elevated plasma endothelial microparticles in preeclampsia. Am J Obstet Gynecol 2003;189:589-593.
12. Jimenez JJ, Jy W, Mauro LM, Horstman LL, Soderland C, Ahn YS. Endothelial microparticles released in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation. Br J Haematol 2003;123:896-902.
13. Horstman LL, Ahn YS. Platelet microparticles: A wide-angle perspective. Crit Rev Oncol Hematol 1999;30:111-142.
14. Biro E, Akkerman JW, Hoek FJ, Gorter G, Pronk LM, Sturk A, Nieuwland R. The phospholipid composition and cholesterol content of platelet-derived microparticles: A comparison with platelet membrane fractions. J Thromb Haemost 2005;3:2754-2763.
15. Furie B, Furie BC. Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation. Trends Mol Med 2004;10:171-178.
16. Combes V, Simon AC, Grau GE, Arnoux D, Camoin L, Sabatier F, Mutin M, Sanmarco M, Sampol J, Dignat-George F. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 1999;104:93-102.
17. Brogan PA, Dillon MJ. Endothelial microparticles and the diagnosis of the vasculitides. Intern Med 2004;43:1115-1119.
18. Chirinos JA, Heresi GA, Velasquez H, Jy W, Jimenez JJ, Ahn E, Horstman LL, Soriano AO, Zambrano JP, Ahn YS. Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol 2005;45:1467-1471.
19. Jurk K, Kehrel BE. Platelets: Physiology and biochemistry. Semin Thromb Hemost 2005;31:381-392.
20. Kehrel BE. Blood platelets: Biochemistry and physiology. Hamostaseologie 2003;23:149-158.
21. van der Zee PM, Biro E, Ko Y, de Winter RJ, Hack CE, Sturk A, Nieuwland R. P-Selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction. Clin Chem 2006;52:657-664.
22. Nikol S, Middendorf K. Risk of thromboembolism and arteriosclerosis in women. Z Kardiol 2002;91:523-535.
23. Winkler UH. Thrombophilia and antithrombotic prevention in gynecology and obstetrics. Internist (Berl) 1997;38:650-657.
24. Nordstrom M, Lindblad B, Bergqvist D, Kjellstrom T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 1992;232:155-160.
25. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd.. Trends in the incidence of deep vein thrombosis and pulmonary embolism: A 25-year population-based study. Arch Intern Med 1998;158:585-593.
26. Hiller E. Cancer and thrombosis: Managing the risks and approaches to thromboprophylaxis. Onkologie 2006;29:474-478.
27. Michota F. Venous thromboembolism: Epidemiology, characteristics, and consequences. Clin Cornerstone 2005;7:8-15.
28. Pihusch V, Rank A, Steber R, Pihusch M, Pihusch R, Toth B, Hiller E, Kolb HJ. Endothelial cell-derived microparticles in allogeneic hematopoietic stem cell recipients. Transplantation 2006;81:1405-1409.
29. Nieuwland R, Berckmans RJ, Rotteveel-Eijkman RC, Maquelin KN, Roozendaal KJ, Jansen PG, ten Have K, Eijsman L, Hack CE, Sturk A. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation 1997;96:3534-3541.
30. Faraday N, Goldschmidt-Clermont PJ, Bray PF. Gender differences in platelet GPIIb-IIIa activation. Thromb Haemost 1997;77:748-754.
31. Zahavi J, Dreyfuss F, Kalef M, Soferman N. Adenosine diphosphate-induced platelet aggregation in healthy women with and without a combined and sequential contraceptive pill. Am J Obstet Gynecol 1973;117:107-113.
32. Larsen LF, Andersen HR, Hansen AB, Andersen O. Variation in risk indicators of cardiovascular disease during the menstrual cycle: An investigation of within-subject variations in glutathione peroxidase, haemostatic variables, lipids and lipoproteins in healthy young women. Scand J Clin Lab Invest 1996;56:241-249.
33. Motomiya T, Yamazaki H. Plasma beta-thromboglobulins and platelet factor 4 during the normal menstrual cycle. Nippon Ketsueki Gakkai Zasshi 1981;44:193-195.
34. Rudnicka AR, Rumley A, Lowe GD, Strachan DP. Diurnal, seasonal, and blood-processing patterns in levels of circulating fibrinogen, fibrin D-dimer, C-reactive protein, tissue plasminogen activator, and von Willebrand factor in a 45-year-old population. Circulation 2007;115:996-1003.
35. Bona R, Lee E, Rickles F. Tissue factor apoprotein: Intracellular transport and expression in shed membrane vesicles. Thromb Res 1987;48:487-500.
36. Satta N, Toti F, Feugeas O, Bohbot A, Dachary-Prigent J, Eschwege V, Hedman H, Freyssinet JM. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J Immunol 1994;153:3245-3255.
37. Giesen PL, Rauch U, Bohrmann B, Kling D, Roque M, Fallon JT, Badimon JJ, Himber J, Riederer MA, Nemerson Y. Blood-borne tissue factor: Another view of thrombosis. Proc Natl Acad Sci USA 1999;96:2311-2315.
38. Del Conde I, Shrimpton CN, Thiagarajan P, Lopez JA. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 2005;106:1604-1611.
39. Feuring M, Christ M, Roell A, Schueller P, Losel R, Dempfle CE, Schultz A, Wehling M. Alterations in platelet function during the ovarian cycle. Blood Coagul Fibrinolysis 2002;13:443-447.
40. Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Variations in coagulation factors in women: Effects of age, ethnicity, menstrual cycle and combined oral contraceptive. Thromb Haemost 1999;82:1456-1461.
41. Giardina EG, Chen HJ, Sciacca RR, Rabbani LE. Dynamic variability of hemostatic and fibrinolytic factors in young women. J Clin Endocrinol Metab 2004;89:6179-6184.
42. Lebech AM, Kjaer A, Lebech PE. Metabolic changes during the normal menstrual cycle: A longitudinal study. Am J Obstet Gynecol 1990;163:414-416.
43. Cederblad G, Hahn L, Korsan-Bengtsen K, Pehrsson NG, Rybo G. Variations in blood coagulation, fibrinolysis, platelet function and various plasma proteins during the menstrual cycle. Haemostasis 1977;6:294-302.
44. Roell A, Schueller P, Schultz A, Losel R, Wehling M, Christ M, Feuring M. Effect of oral contraceptives and ovarian cycle on platelet function. Platelets 2007;18:165-170.
45. Haque SF, Matsubayashi H, Izumi S, Sugi T, Arai T, Kondo A, Makino T. Sex difference in platelet aggregation detected by new aggregometry using light scattering. Endocr J 2001;48:33-41.
46. Monte S, Lyons G. In vitro evidence of gender-related heparin resistance. Int J Obstet Anesth 2004;13:91-94.
47. Johnson M, Ramey E, Ramwell PW. Sex and age differences in human platelet aggregation. Nature 1975;253:355-357.
48. Koga H, Sugiyama S, Kugiyama K, Watanabe K, Fukushima H, Tanaka T, Sakamoto T, Yoshimura M, Jinnouchi H, Ogawa H. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 2005;45:1622-1630.
49. Majmudar NG, Robson SC, Ford GA. Effects of the menopause, gender, and estrogen replacement therapy on vascular nitric oxide activity. J Clin Endocrinol Metab 2000;85:1577-1583.
50. Perregaux D, Chaudhuri A, Mohanty P, Bukhari L, Wilson MF, Sung BH, Dandona P. Effect of gender differences and estrogen replacement therapy on vascular reactivity. Metabolism 1999;48:227-232.
51. Forte P, Kneale BJ, Milne E, Chowienczyk PJ, Johnston A, Benjamin N, Ritter JM. Evidence for a difference in nitric oxide biosynthesis between healthy women and men. Hypertension 1998;32:730-734.
52. Celi A, Lorenzet R, Furie BC, Furie B. Microparticles and a P-selectin-mediated pathway of blood coagulation. Dis Markers 2004;20:347-352.